Quants Research Institute Holdings Inc (9552) Q3 2025 earnings summary

Executive summary

• Consolidated net sales for Q3 FY2025 were ¥11,597mn, down 9.2% year-over-year, with operating profit at ¥3,243mn, a 53.8% decline year-over-year, and an operating margin of 28.0% versus 55.0% a year earlier.

• Ordinary profit declined 53.7% year-over-year to ¥3,247mn, and profit attributable to owners of parent fell 57.5% to ¥1,913mn.

• Declines attributed to slower productivity recovery in M&A brokerage and upfront investments in incubation business.

• The M&A brokerage segment closed 175 deals, while the consulting and asset management segment saw significant sales growth but posted a segment loss.

• The company established subsidiaries in Singapore and for operating leases, aiming to diversify revenue and expand overseas.

Financial highlights

• Q3 FY2025 consolidated net sales: ¥11,597mn (-9.2% YoY); operating profit: ¥3,243mn (-53.8% YoY); net income: ¥1,912mn (-57.5% YoY).

• M&A brokerage Q3 net sales: ¥10,724mn (-15.4% YoY); operating profit: ¥3,945mn (-45.5% YoY); operating margin: 36.8%.

• Incubation/consulting segment Q3 net sales: ¥872mn (+785.2% YoY); operating loss: ¥654mn.

• Gross profit margin declined to 60.5% from 75.3% a year earlier.

• Net income per share was ¥32.90, compared to ¥76.87 in the prior year period.

Outlook and guidance

• FY2025 full-year net sales forecast: ¥17,950mn (+8.5% YoY); operating profit: ¥5,732mn (-31.8% YoY); profit: ¥3,960mn (-31.6% YoY).

• M&A brokerage FY2025 net sales forecast: ¥16,500mn (+1.2% YoY); operating profit: ¥6,400mn (-26.4% YoY); operating margin: 38.8%.

• Incubation segment net sales forecast: ¥1,450mn (+487.0% YoY); operating loss: ¥668mn.

• No revision to earnings forecast anticipated as Q3 operating profit progress rate is 56.6% of full-year plan.

• Actual results may differ due to various factors.